drugset / Trial / NCT00485108
Anti-inflammatory Therapy Following Selective Laser Trabeculoplasty
Completed
120 enrolled
Queen's University
Glaucoma Research Society of Canada · collabPfizer · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The type of anti-inflammatory medication used post selective laser trabeculoplasty (SLT) may have an impact on the intra-ocular pressure (IOP) lowering effect of SLT. This study will evaluate the IOP lowering effect of SLT following the topical administration of one of the following: prednisolone 1%, ketorolac 0.5% or artificial tears.
Timeline
- Start
- 2007-01
- Primary completion
- 2009-06
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ketorolac | Other / unclassified | 0.5 % | Topical |
| Comparator | Prednisolone | Other / unclassified | 1 % | Topical |